Diagnostic Performance of Positron Emission Tomography in the Detection of Coronary Artery Disease: A Meta-analysis 1
|
|
- Bathsheba Dennis
- 5 years ago
- Views:
Transcription
1 Diagnostic Performance of Positron Emission Tomography in the Detection of Coronary Artery Disease: A Meta-analysis 1 Kiran R. Nandalur, MD, Ben A. Dwamena, MD, Asim F. Choudhri, MD Sirisha R. Nandalur, MD, Priya Reddy, Ruth C. Carlos, MD Rationale and Objectives. Although myocardial perfusion positron emission tomography (PET), using either cyclotronproduced ammonia or generator-produced rubidium 82, has reported excellent diagnostic capabilities in the detection of coronary artery disease (CAD) in individual studies, the technique is not widely used in practice. This may be driven by cost and availability or by unawareness of performance. The purpose of our study was to conduct an evidence-based evaluation of PET in the diagnosis of CAD. Materials and Methods. We examined studies from January 1977 to July 2007 using MEDLINE and EMBASE. A study was included if it (1) used PET as a diagnostic test for CAD and (2) used catheter x-ray angiography as the reference standard ( 50% diameter stenosis). Analysis was performed on a subject and coronary territory level. Results. Nineteen studies (1442 patients) met the inclusion criteria. On a patient level, PET demonstrated a sensitivity of 0.92 (95% confidence interval [CI]: ) and specificity of 0.85 (CI: ), with a positive likelihood ratio (LR ) of 6.2 (CI: ) and negative likelihood ratio (LR ) of 0.11 (CI: ). On a coronary territory level (n 1130), PET showed a sensitivity of 0.81 (CI: ) and specificity of 0.87 (CI: ), with an LR of 5.9 (CI: ) and an LR of 0.19 (CI: ). Conclusion. PET demonstrates excellent diagnostic properties in the diagnosis of CAD, especially at the patient level. The capabilities appear superior to those reported in meta-analyses for perfusion imaging with Tl-201 and sestamibi, or anatomical imaging with coronary MDCT angiography or MRA. Given that previous studies have found PET to be costeffective and the current findings of excellent sensitivity and specificity, the modality should be more widely considered as an initial test in the diagnosis of CAD. Key Words. Meta-analysis; positron emission tomography; coronary disease. AUR, 2008 Acad Radiol 2008; 15: From the Department of Radiology, University of Michigan Health System, Ann Arbor, MI (K.R.N., B.A.D., R.C.C.); Department of Nuclear, Veterans Affairs, Ann Arbor Health Care System, Ann Arbor, MI (B.A.D.); Department of Radiology, University of Virginia Health System, Charlottesville, VA (A.F.C.); and Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI (S.R.N.). Current address: Department of Radiology, William Beaumont Hospital, 3601 W 13 Mile Rd, Royal Oak, MI (K.R.N., P.R.). Address correspondence to: K.R.N. nandalurk@yahoo.com AUR, 2008 doi: /j.acra
2 Academic Radiology, Vol 15, No 4, April 2008 META-ANALYSIS OF PET FOR CORONARY DISEASE Coronary artery disease (CAD), secondary to atherosclerosis, is the leading cause of mortality in the United States, underlying or contributing to approximately 650,000 deaths per year (1). While catheter-based x-ray angiography evaluation of the coronary lumen is generally used as the clinical reference standard, the invasive procedure carries small but significant risks; thus, a potential noninvasive alternative would be valuable. Radionuclide myocardial perfusion imaging is one of the most common used diagnostic tests in the assessment of CAD and largely performed by thallium-201 or a technetium-99m perfusion tracer via single-photon emission computed tomography (SPECT). However, myocardial perfusion positron emission tomography (PET), which has several advantages over SPECT, including better spatial resolution, higher counting efficiencies, and excellent attenuation correction, resulting in single-center studies demonstrating robust sensitivity and specificity, is less commonly performed throughout the world. This is likely driven by the greater availability and lesser costs of SPECT, but lack of awareness regarding the diagnostic properties of PET in the diagnosis of CAD may also be a factor. Moreover, PET has become more prevalent and less expensive in the last decade, given its widespread use in oncological imaging. The purpose of our study was to provide an evidence-based evaluation of the clinical utility of PET for coronary artery disease; thus, we performed a comprehensive meta-analysis of all currently published studies comparing PET with catheter-based x-ray angiography as the gold standard. METHODS Data Sources and Searches MEDLINE and EMBASE for English and non-english literature published from January 1977 to July 2007 were searched evaluating for the presence of CAD in native or non-native coronary arteries by PET and catheter-based x-ray angiography in the same patients. The search included medical subject headings for positron emission tomography, myocardial perfusion, and coronary angiography with the exploded term coronary artery disease. Moreover, we evaluated bibliographies of retrieved articles, review articles, and textbooks. The retrieved studies were examined for potentially duplicate or overlapping data. Given that meeting abstracts provide insufficient information regarding their data and lack of finality regarding the results, they were excluded. Study Selection A study was included if (a) it used PET as a diagnostic test for obstructive CAD, with 50% diameter stenosis selected as the threshold for significant CAD, using catheter-based x-ray angiography as the reference standard and (b) reported cased in absolute numbers of true positive (TP), false positive (FP), true negative (TN), and false negative (FN) results or stated data adequate to derive this information. Studies were eligible regardless of whether they were referred for suspected or known CAD and regardless of technique used for PET. Studies were excluded if performed in (a) phantom-only models, (b) animals, or (c) normal healthy volunteers without catheter-based x-ray angiography correlation or (d) included fewer than 10 patients. Data Extraction and Quality Assessment Data extraction was performed by two independent investigators. Inconsistencies were resolved by discussion and consensus. The following information was extracted from each study: first author, year of publication, journal, location of study, and study population (number of patients examined with both test and number of diagnostic and nondiagnostic); number of patients with CAD; and gender, mean age, and technical characteristics of PET. Data were recorded, as available, at the patient level and coronary territory level (left anterior descending, left circumflex, and right coronary artery). Study quality and applicability were assessed by a modified checklist based on the Quality Assessment Tool for Diagnostic Accuracy (QUADAS) guidelines by two independent investigators, with discrepancies solved by consensus (2). Data Synthesis and Statistical Analysis The main analysis was performed at the patient level, as most studies focused on this level of information. Secondary analyses were performed at the coronary territory level. We applied the bivariate mixed-effects regression model for treatment trial meta-analysis and modified for synthesis of diagnostic test data assuming binomial errors distribution for sensitivity and specificity (3). Betweenstudy variability was assessed assuming correlated normally distributed random effects for logit (sensitivity) and logit (specificity) with the degree of correlation between predictive of an implicit threshold effect. We derived summary sensitivity, and specificity as functions of the estimated model parameters. Likelihood ratios (LR) are metrics that express how much the odds change for the presence of CAD if there is a positive (abnormal) PET 445
3 NANDALUR ET AL Academic Radiology, Vol 15, No 4, April 2008 (positive likelihood ratio: LR ) and also how much the odds change for the presence of CAD with a negative PET (negative likelihood ratio: LR ). LR and LR are defined with the following formulas: LR sensitivity/ (1 sensitivity) and LR (1 sensitivity)/specificity. Assessment of Heterogeneity Heterogeneity of the results between the studies was assessed graphically by forest plots and statistically using the quantity I 2 that describes the percentage of total variation across studies attributable to heterogeneity rather than chance. I 2 can be calculated from basic results as I 2 100% (Q df)/q, where Q is Cochran s heterogeneity statistic and df is the degrees of freedom. I 2 lies between 0% and 100%. A value of 0% indicates no observed heterogeneity, and values greater than 50% may be considered substantial heterogeneity. Statistical analyses were performed with Stata 9.0 (Chicago, II). ruling out disease), PET is excellent at confirming and excluding CAD (23). Coronary Territory-Level Summary Performance Estimates Per-coronary territory meta-analysis of PET pooled 9 datasets with 1130 coronary territories and demonstrated a sensitivity of 0.81 (CI: ) and specificity of 0.87 (CI: ) (Fig. 2) with an LR of 5.9 (CI: ) and an LR of 0.19 (CI: ). The prevalence of CAD by territory was 43.4% (407 of 1130). Assessment of Heterogeneity Analysis at the patient level demonstrated no significant heterogeneity between PET studies in sensitivities (I , p.36) but significant heterogeneity involving specificities (I , p.001). At the coronary territory level, heterogeneity was present between study sensitivities (I , p.001) and specificities (I , p.03). Quality grading by study is shown in Table 3. RESULTS Database searches identified 25 potentially relevant citations. Nineteen studies were included, with 6 being excluded because (a) they had overlapping data or (b) it was not possible to calculate absolute figures from the presented data. Study and population characteristics of the included studies are summarized in Table 1 (4 22). Data on diagnostic accuracy were available for the 19 studies with a total of 1442 patients. Results of the individual studies on a per-patient and per-coronary territory level are summarized in Table 2. Patient-Level Summary Performance Estimates After pooling 14 datasets (840 patients after exclusion of 2 patients secondary to unsuccessful PET), PET demonstrated a sensitivity of 0.92 (95% confidence interval [CI]: ) and specificity of 0.85 (CI: ) (Fig. 1). The prevalence of CAD in this group was 77.4% (650 of 840). Overall, these summary estimates show excellent sensitivity and specificity for CAD at the patient level. Evaluating clinical utility, the LR for PET was 6.2 (CI: ), and the LR was 0.11 (CI: ). Using the rule of thumb that for a diagnostic test to be useful it should have a high LR ( 5) (i.e., good at ruling in a disease) and a low LR ( 0.2) (i.e., good at DISCUSSION PET has increased in availability and gained widespread acceptance for use in oncology diagnosis over the past decade, given the vast amount of evidence supporting its utility. However, although there is similar evidence regarding its usefulness in cardiac imaging, PET is not routinely used by many centers throughout the world. PET has been shown to be cost-effective in the work-up of CAD relative to exercise testing, SPECT, and immediate angiography (24). Moreover, myocardial perfusion imaging with PET has significant prognostic value for predicting cardiac events, such as death and myocardial infarction, including patients whose diagnosis is less certain after SPECT and obese patients (25). To date, a comprehensive analysis of the data analyzing the use of PET in the diagnosis of CAD has not been performed, which could potentially increase the awareness of the modality. Our study found in an overall patient population with a high prevalence of diseases, PET has excellent sensitivity (92%) and specificity (85%) for detecting luminal stenoses 50%. Moreover, the positive and negative likelihood conferred by an abnormal and normal test, respectively, is also exceptional. The ability of PET to detect CAD appears superior to other modalities that perform functional imaging of the 446
4 447 Table 1 Characteristics of Included Studies First Author (Ref.) Year Journal Patients (N) Excluded Male (%) Abramson (4) 2000 Journal of Nuclear Bateman (5) 2006 Journal of Nuclear Botsch (6) 1994 European Journal of Nuclear Go (7) 1990 Journal of Nuclear Gould (8) 1986 Journal of the American College of Grover-McKay (9) 1992 American Heart Journal Laubenbacher (10) 1993 Journal of Nuclear Marwick (11) 1992 Journal of the American Society of Echocardiography Muzik (12) 1998 Journal of the American College of Namdar (13) 2005 Journal of Nuclear Sampson (14) 2007 Journal of the American College of Santana (15) 2007 Journal of Nuclear Schelbert (16) 1982 American Journal of Simone (17) 1992 American Journal of Physiologic Imaging Stewart (18) 1991 American Journal of Mean Age, yr (SD) PET Radiotracer Stressor Selection Stenosis (10) F-18 deoxyglucose (FDG) Treadmill n 8, dipyridamole n 11 Women referred for chest pain 50% NS NS Rubidium-82 Dipyridamole Suspected CAD 50% 31 0 NS NS 27 rubidium-82/23 nitrogen-13 (N-13) (NS) Rubidium-82 Dipyridamole Matched casecontrol 70% 34 0 NS 56 (NS) Rubidium-82 Exercise Suspected CAD 50% Dipyridamolehandgrip stress Suspected CAD CFR (11) Rubidium-82 Dipyridamolehandgrip stress 16 with known CAD 50% 29 0 NS 61 (11) Nitrogen-13 (N-13) Dipyridamole or Suspected CAD 75% adenosine (4) Rubidium-82 Dipyridamolehandgrip Known CAD 50% stress (12) Nitrogen-13 (N-13) Adenosine 31 with CAD 70% (NS) Nitrogen-13 (N-13) PET/CT Known CAD 50% (15) Rubidium-82 PET/CT (dipyridamole, adenosine, dobutamine) Suspected CAD 70% 53 NS 29 NS Rubidium-82 PET/CT Known or 50% (adenosine) Suspected CAD NS Nitrogen-13 (N-13) Dipyridamole 32 with CAD/13 50% normal volunteers 225 NS (NS) Rubidium-82 Dipyridamole Suspected CAD 67% (12) Rubidium-82 Dipyridamolehandgrip stress Suspected CAD 50% Academic Radiology, Vol 15, No 4, April 2008 META-ANALYSIS OF PET FOR CORONARY DISEASE
5 NANDALUR ET AL Academic Radiology, Vol 15, No 4, April 2008 Table 1 (Continued) Mean Age, yr (SD) PET Radiotracer Stressor Selection Stenosis First Author (Ref.) Year Journal Patients (N) Excluded Male (%) NS 25 0 NS 53 (NS) Nitrogen-13 (N-13) Exercise 19 known CAD/6 normal volunteers Tamaki (19) 1985 European Journal of Nuclear 51 0 NS 56 (NS) Nitrogen-13 (N-13) Exercise Known CAD 50% Tamaki (20) 1988 Journal of Nuclear 287 NS NS NS Rubidium-82 Dipyridamole Suspected CAD 67 Williams (21) 1994 Journal of Nuclear (NS) Nitrogen-13 (N-13) Exercise 40 with known CAD 75% Yonekura (22) 1987 American Heart Journal NS, not specified. heart. Recently, the emerging technique of stress cardiac magnetic resonance imaging (MRI) using either perfusion imaging or wall-motion imaging has shown promise, with stress-induced wall motion abnormalities imaging demonstrating a sensitivity of 83% and specificity of 86% and perfusion imaging demonstrating a sensitivity of 91% and specificity of 81% (26). A recent meta-analysis demonstrated a sensitivity of 86% and specificity of 74% for SPECT for CAD (27), and a sensitivity and specificity of 84% and 82% for stress echocardiography for CAD (28). Although the numbers for stress MRI, SPECT, and echocardiography are good, PET seems to exhibit the best combination of sensitivity and specificity. Moreover, in head-to-head studies, PET has compared favorably in diagnostic capabilities relative to SPECT (5,7,18). The robust capabilities of PET in detection of CAD has several underlying explanations. PET has excellent spatial and temporal resolution relative to SPECT, with greater myocardial count density. Bateman et al. (5) found that the PET count exceeded that of SPECT by a factor of 2, despite shorter imaging times: 5 minutes for PET versus 16 minutes for SPECT. This better count density allows for superior quality images and reslicing at 3 mm rather than the conventional 6 mm. PET also has an estimated theoretical tomographic in-plane spatial resolution of 2 to 4 mm compared to 6 to 8 mm for Tc-99m SPECT (full width at half maximum), which permits superior discernment of the myocardium from adjacent structures. Next, the sensitivity of PET may be better secondary to the characteristics of the tracer. Relative to Tc- 99m SPECT perfusion tracers, Rb-82 chloride is well extracted by the myocardium and the uptake is more linearly related to increases in coronary blood flow, as opposed to Tc-99m tracers, which plateau at relatively low flows. Moreover, PET, as opposed to SPECT, shows promise in not only detecting luminal stenoses but also characterizing atherosclerotic plaque inflammation, which is important, as recent studies have demonstrated that plaque characteristics may play a key role in the development of symptoms (29 31). There are several limitations to our study. First, the prevalence of disease in the study populations was high (77.4%), likely secondary to selection/verification bias favoring patients with abnormal PET scans to undergo invasive angiography. Next, significant heterogeneity was identified in multiple performance characteristics; thus, the results and potential clinical application should be interpreted with caution. Next, the quality of the studies, many performed before 2000, are generally low (scale 448
6 Academic Radiology, Vol 15, No 4, April 2008 META-ANALYSIS OF PET FOR CORONARY DISEASE Table 2 Per Patient, Per Coronary Territory Analysis Analysis by Patient Analysis by Coronary Territory First Author (Ref) N TP (n) FN (n) FP (n) TN (n) Sensitivity Specificity N TP (n) FN (n) FP (n) TN (n) Sensitivity Specificity Abramson (4) NS NS NS NS NS NS NS Bateman (5) NS NS NS NS NS NS NS Botsch (6) NS NS NS NS NS NS NS Go (7) NS NS NS NS NS NS NS Gould (8) NS NS NS NS NS NS NS Grover-McKay (9) Laubenbacher (10) NS NS NS NS NS NS NS Marwick (11) NS NS NS NS NS NS NS Muzik (12) NS NS NS NS NS NS NS Namdar (13) NS NS NS NS NS NS NS Sampson (14) NS NS NS NS NS NS NS Santana (15) Schelbert (16) NS NS NS NS NS NS NS Simone (17) NS NS NS NS NS NS NS Stewart (18) NS NS NS NS NS NS NS Tamaki (19) NS NS NS NS NS NS NS Tamaki (20) Williams (21) NS NS NS NS NS NS NS Yonekura (22) NS, not specified. Figure 1. Forest plots of patient-level sensitivity and specificity. A, Forest plot of sensitivity of PET compared with coronary angiography (CXA). B, Forest plot of specificity of PET. Filled box indicates point estimate of each study (area indicates relative contribution of the study to meta-analysis); horizontal line, 95% confidence interval (95% CI). 1 10, mean score 5.8, standard deviation 1.7), with many not providing comprehensive data at the patient and coronary territory levels. Next, the bias to publish studies with positive results, publication bias, confounds evaluation. Finally, although the availability of PET is increasing, the modality, specifically the equipment and radiotracer, is expensive and not widely available outside the United States. Moreover, radiation exposure remains a concern, especially when performed in conjunction with CT. For example, in a recent study by Sampson et al. 449
7 NANDALUR ET AL Academic Radiology, Vol 15, No 4, April 2008 Figure 2. Forest plots of coronary territory level sensitivity and specificity. A, Forest plot of sensitivity of PET compared with coronary angiography (CXA). B, Forest plot of specificity of PET. Filled box indicates point estimate of each study (area indicates relative contribution of the study to meta-analysis); horizontal line, 95% confidence interval (95% CI). Table 3 Quality Assessment First Author (Ref) Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Score Abramson (4) Yes Yes Yes No Yes Yes Yes Yes No No 7 Bateman (5) Yes No Yes No No Yes Yes Yes Yes Yes 7 Botsch (6) No No Yes No No Yes Yes No No No 3 Go (7) Yes No Yes No No Yes Yes No Yes No 5 Gould (8) Yes No Yes No Yes Yes Yes No No No 5 Grover-McKay (9) Yes No Yes No Yes Yes Yes No No No 5 Laubenbacher (10) No No Yes No Yes Yes Yes Yes No No 5 Marwick (11) Yes Yes Yes No Yes Yes Yes No Yes No 7 Muzik (12) Yes Yes No No Yes Yes Yes No No No 5 Namdar (13) Yes No Yes No Yes Yes Yes No No No 5 Sampson (14) Yes No Yes Yes Yes Yes Yes Yes Yes Yes 9 Santana (15) Yes No Yes No Yes Yes Yes Yes Yes Yes 8 Schelbert (16) No No Yes No Yes Yes Yes No Yes No 5 Simone (17) Yes No Yes No No Yes Yes Yes Yes No 6 Stewart (18) Yes No Yes No Yes Yes Yes No Yes Yes 7 Tamaki (19) No No Yes No No Yes No No No No 2 Tamaki (20) Yes Yes Yes No Yes Yes Yes No Yes No 7 Williams (21) Yes No Yes No No Yes Yes No Yes No 5 Yonekura (22) Yes No Yes No Yes Yes Yes No Yes Yes 7 Item 1: Was the population clinically relevant, defined as a group of patients covering the spectrum of disease that is likely to be encountered in the current or future use of the test? Item 2: Was there complete verification by the reference standard? Item 3: Was there blinded interpretation of the test results? Item 4: Was there consecutive patient selection? Item 5: Was there prospective enrollment of patients? Item 6: Was there adequate description and quality of the imaging procedure? Item 7: Was the quality of the reference test technically adequate? Item 8: Was there adequate clinical description of the patient population? Item 9: Was the sample size 35 patients? Item 10: Was there adequate reporting of results, including summary and subgroup indices of accuracy? 450
8 Academic Radiology, Vol 15, No 4, April 2008 META-ANALYSIS OF PET FOR CORONARY DISEASE (14) using PET CT, the effective radiation dosimetry was 13.8 msv (12 msv from the rest-stress Rb-82 injections, 1.4 msv from the two CT transmission scans, and 0.4 from the two scout scans), which is relatively high. In conclusion, an evidence-based evaluation of PET demonstrates excellent sensitivity and specificity in diagnosis of coronary artery disease. Based on the current findings, increasing availability, and cost-effectiveness, PET should have an expanding role in the realm of noninvasive cardiac imaging. REFERENCES 1. Thom T, Haase N, Rosamond W, et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85 e Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: Abramson BL, Ruddy TD, dekemp RA, et al. Stress perfusion/metabolism imaging: A pilot study for a potential new approach to the diagnosis of coronary disease in women. J Nucl Cardiol 2000; 7: Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/ stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006; 13: Botsch H, Beringer K, Petersen J, et al. Single-photon emission tomography studies of rubidium-81 in the detection of ischaemic heart disease, using a stress-reinjection protocol. Eur J Nucl Med 1994; 21: Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990; 31: Gould KL, Goldstein RA, Mullani NA, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol 1986; 7: Grover-McKay M, Ratib O, Schwaiger M, et al. Detection of coronary artery disease with positron emission tomography and rubidium 82. Am Heart J 1992; 123: Laubenbacher C, Rothley J, Sitomer J, et al. An automated analysis program for the evaluation of cardiac PET studies: Initial results in the detection and localization of coronary artery disease using nitrogen-13- ammonia. J Nucl Med 1993; 34: Marwick TH, Nemec JJ, Stewart WJ, et al. Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: Comparison and analysis of discrepant results. J Am Soc Echocardiogr 1992; 5: Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998; 31: Namdar M, Hany TF, Koepfli P, et al. Integrated PET/CT for the assessment of coronary artery disease: A feasibility study. J Nucl Med 2005; 46: Sampson UK, Dorbala S, Limaye A, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007; 49: Santana CA, Folks RD, Garcia EV, et al. Quantitative (82)Rb PET/CT: Development and validation of myocardial perfusion database. J Nucl Med 2007; 48: Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 1982; 49: Simone GL, Mullani NA, Page DA, et al. Utilization statistics and diagnostic accuracy of a nonhospital-based positron emission tomography center for the detection of coronary artery disease using rubidium-82. Am J Physiol Imaging 1992; 7: Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991; 67: Tamaki N, Yonekura Y, Senda M, et al. Myocardial positron computed tomography with 13N-ammonia at rest and during exercise. Eur J Nucl Med 1985; 11: Tamaki N, Yonekura Y, Senda M, et al. Value and limitation of stress thallium-201 single photon emission computed tomography: Comparison with nitrogen-13 ammonia positron tomography. J Nucl Med 1988; 29: Williams BR, Mullani NA, Jansen DE, et al. A retrospective study of the diagnostic accuracy of a community hospital-based PET center for the detection of coronary artery disease using rubidium-82. J Nucl Med 1994; 35: Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomography. Am Heart J 1987; 113: Sistrom CL, Garvan CW. Proportions, odds, and risk. Radiology 2004; 230: Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995; 91: Yoshinaga K, Chow BJ, Williams K, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006; 48: Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: A meta-analysis. J Am Coll Cardiol 2007; 50: Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 2004; 31: Bax JJ, Van der Wall EE, De Roos A, et al. State of the art and future directions. In: Zaret Bl, Beller GA, eds. Clinical Nuclear. Philadelphia: Mosby, Nandalur KR, Baskurt E, Hagspiel KD, et al. Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol 2005; 184: Nandalur KR, Hardie AD, Raghavan P, et al. Composition of the stable carotid plaque: Insights from a multidetector computed tomography study of plaque volume. Stroke 2007; 38: Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006; 48:
Advantages of PET Myocardial Imaging
Advantages of PET Myocardial Imaging Legal Disclaimers These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationPET for the Evaluation of Myocardial Viability
PET for the Evaluation of Myocardial Viability Myocardial viability assessment is an important part of cardiac PET to assist physicians to decide upon the best surgical or medical procedures. F-18 FDG
More informationCARDIAC PET PERFUSION IMAGING with RUBIDIUM-82
CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 Pr Denis AGOSTINI Président du Groupe de Cardiologie Nucléaire et IRM CHU Caen Bordeaux 2006 Cardiac Perfusion-Metabolism Mismatch with PET Cumulative Survival
More informationDoes Rubidium-82 PET Have Superior Accuracy to SPECT Perfusion Imaging for the Diagnosis of Obstructive Coronary Disease?
Journal of the American College of Cardiology Vol. 60, No. 18, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.038
More informationJournal of the American College of Cardiology Vol. 49, No. 10, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 49, No. 10, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.12.015
More informationCardiac Imaging Tests
Cardiac Imaging Tests http://www.medpagetoday.com/upload/2010/11/15/23347.jpg Standard imaging tests include echocardiography, chest x-ray, CT, MRI, and various radionuclide techniques. Standard CT and
More informationMyocardial Perfusion: Positron Emission Tomography
Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support
More informationPerspectives of new imaging techniques for patients with known or suspected coronary artery disease
Perspectives of new imaging techniques for patients with known or suspected coronary artery disease Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands Correspondence: Jeroen
More informationPromising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging
Journal of Nuclear Medicine, published on July 30, 2015 as doi:10.2967/jnumed.115.161661 Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging Richard C. Brunken MD, FACC, FAHA,
More informationNUCLEAR CARDIOLOGY UPDATE
Nuclear Cardiology David K. Shelton, Jr., MD NUCLEAR CARDIOLOGY UPDATE No Conflicts. No Disclosures. No Smoking. David K. Shelton UCDMC Nuclear Cardiology Nuclear Cardiology Radionuclide Ventriculography
More informationNuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN
Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN VUMC PET/CT conference 2009 82 Rb Cardiac Perfusion PET 82 Rb is
More informationConflict of Interest Disclosure
Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas
More informationRubidium-82 myocardial perfusion PET/CT
Rubidium- myocardial perfusion PET/CT A.M. Scholtens, MD 1 ; P.C. Barneveld, MD 2 Departments of Nuclear Medicine of 1 Meander Medical Center, Amersfoort, the Netherlands, and 2 Jeroen Bosch Hospital,
More informationThe diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh
The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh Key points 1) Coronary artery disease in women differs from men in several ways,
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
PET Scanning: Cardiac Applications Page 1 of 31 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Positron Emission Tomography (PET) Scanning: Cardiac Applications
More informationEvidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease
Editorial Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease Zhonghua Sun Discipline of Medical Imaging, Department of Imaging and Applied
More informationClick here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.
Final Compared to 3Q 2017 Rates Medicare Hospital Outpatient Prospective Payment System HOPPS () Nuclear Cardiology Procedures, Radiopharmaceuticals, and Drugs Click here for Link to References: CMS Website
More informationSPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος
SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος Δρ Αναστασία Κίτσιου Διευθύντρια, Καρδιολογική Κλινική, Σισμανόγλειο ΓΝΑ Chair, Education Committee, Section on Nuclear Cardiology & Cardiac CT, EACVI, ESC
More informationMedical Policy. MP Cardiac Applications of Positron Emission Tomography Scanning
Medical Policy BCBSA Ref. Policy: 6.01.20 Last Review: 09/19/2018 Effective Date: 09/19/2018 Section: Radiology Related Policies 6.01.51 Interim Positron Emission Tomography Scanning in Oncology to Detect
More informationPearls & Pitfalls in nuclear cardiology
Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer
More informationTest in Subjects with Suspected CAD Anatomic Study is Better
Test in Subjects with Suspected CAD Anatomic Study is Better Hyuk Jae Chang MD, PhD Division of Cardiology Severance Cardiovascular Hospital Seoul Korea Functional Test Two Issues Accuracy of stress-tests
More informationJe bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.
Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Ces fonds proviennent essentiellement d industriels travaillant dans les domaines de l imagerie
More informationTreadmill Exercise Produces Larger Perfusion Defects Than Dipyridamole Stress N-13 Ammonia Positron Emission Tomography
Journal of the American College of Cardiology Vol. 47, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.09.027
More informationPreview of Presentation
Preview of Presentation Discuss Healthcare Environment Clinical Implementation of Technical Innovations SNMMI/ASNC Joint Statement on Rb-82 Cardiac PET Imaging Protocol Principles of Rb-82 Cardiac Imaging
More informationPhoton Attenuation Correction in Misregistered Cardiac PET/CT
Photon Attenuation Correction in Misregistered Cardiac PET/CT A. Martinez-Möller 1,2, N. Navab 2, M. Schwaiger 1, S. G. Nekolla 1 1 Nuklearmedizinische Klinik der TU München 2 Computer Assisted Medical
More informationHorizon Scanning Technology Summary. Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease
Horizon Scanning Technology Summary National Horizon Scanning Centre Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease April 2007 This technology summary is based
More informationHybrid imaging of the heart
Pärnu (Estonia) Friday, October 10, 2014 8:00-8:30 a.m Hybrid imaging of the heart María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra mjgarciave@unav.es Hibrid imaging
More informationGeneral Cardiovascular Magnetic Resonance Imaging
2 General Cardiovascular Magnetic Resonance Imaging 19 Peter G. Danias, Cardiovascular MRI: 150 Multiple-Choice Questions and Answers Humana Press 2008 20 Cardiovascular MRI: 150 Multiple-Choice Questions
More informationAtypical pain and normal exercise test
Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical
More informationCardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.
National Imaging Associates, Inc. Clinical guidelines CARDIOVASCULAR NUCLEAR MEDICINE -MYOCARDIAL PERFUSION IMAGING -MUGA CPT4 Codes: Refer to pages 6-9 LCD ID Number: L33960 J 15 = KY, OH Responsible
More informationCardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.
National Imaging Associates, Inc. Clinical guidelines CARDIOVASCULAR NUCLEAR MEDICINE -MYOCARDIAL PERFUSION IMAGING -MUGA Original Date: October 2015 Page 1 of 9 FOR CMS (MEDICARE) MEMBERS ONLY CPT4 Codes:
More informationΗ Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ
Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ huma human n Setting diagnosis of the early stages of chronic diseases (i.e cancer, neuropsychiatric, cardiovascular disorders), in
More informationEmerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas
Emerging role of PET in nuclear cardiology Dr. Erick Alexánderson Rosas PET principles e + e - 180 PET/CT Cyclotron Unit UNAM Cyclotron Radiopharmacy PET Camera CT PET PET CT Perfusion Anatomic evaluation
More informationMagnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 15 Magnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability An Evidence-Based Analysis Presented to the Ontario Health
More informationCalcium scoring Clinical and prognostic value
Calcium scoring Clinical and prognostic value Matthijs Oudkerk Professor and Chair of Radiology University Medical Center Groningen, University of Groningen Groningen, The Netherlands Sofia 2011 13 May
More informationCurrent and Future Imaging Trends in Risk Stratification for CAD
Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction
More informationI have no financial disclosures
Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic
More information21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease
21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,
More informationPositron emission tomography and molecular imaging
Positron emission tomography and molecular imaging EHH, May, 2010 Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi PET Imaging in Medicine MRI CT MRI PET US SPET MEG
More informationPET myocard perfusion & viability Riemer Slart
PET myocard perfusion & viability Riemer Slart Nuclear Medicine Physician Dept. of Nuclear Medicine and Molecular Imaging University Medical Center Groningen, the Netherlands Professor in Molecular Imaging,
More informationCardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI
Cardiac Imaging Kimberly Delcour, DO, FACC Director, Cardiac CT Mahi Ashwath, MD, FACC, FASE Director, Cardiac MRI Cardiac Imaging Discuss the clinical applications of and indications for: Cardiac CT Nuclear
More informationOriginal Policy Date
MP 6.01.11 Cardiac Applications of PET Scanning Medical Policy Section Radiology Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical
More informationDisclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview
GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September Disclosures None relevant to this presentation Mini Pakkal Assistant Professor of Radiology University
More informationRADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING
RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING RAYMOND TAILLEFER, M.D. FRCP(c), ABNM DIRECTOR, DEPARTMENT OF NUCLEAR MEDICINE HOPITAL ST-JEAN-SUR-RICHELIEU Disclosures to Report: Grant Research Support:
More informationSPECT or PET for Cardiovascular Screening in High-Risk Patients
SPECT or PET for Cardiovascular Screening in High-Risk Patients Paeng, Jin Chul MD PhD Department of Nuclear Medicine Seoul National University Hospital Contents Recent Development in SPECT and PET Technology
More informationTITLE: Multi-Slice Computed Tomography Coronary Angiography for Coronary Artery Disease: A Review of the Clinical Effectiveness and Guidelines
TITLE: Multi-Slice Computed Tomography Coronary Angiography for Coronary Artery Disease: A Review of the Clinical Effectiveness and Guidelines DATE: 25 February 2009 CONTEXT AND POLICY ISSUES: Coronary
More informationPhysiological Assessment of Myocardial Perfusion Using Nuclear Cardiology Would Enhance Coronary Artery Disease Patient Care
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp CONTROVERSIES IN CARDIOVASCULAR MEDICINE Physiological Assessment of Myocardial Perfusion Using Nuclear
More informationRisk Stratification for CAD for the Primary Care Provider
Risk Stratification for CAD for the Primary Care Provider Shimoli Shah MD Assistant Professor of Medicine Directory, Ambulatory Cardiology Clinic Knight Cardiovascular Institute Oregon Health & Sciences
More informationGated blood pool ventriculography: Is there still a role in myocardial viability?
Gated blood pool ventriculography: Is there still a role in myocardial viability? Oliver C. Alix, MD Adult Clinical and Nuclear Cardiology St. Luke s Medical Centre - Global City Case Presentation A 62-year-old
More informationMyocardial Perfusion SPECT How to do it E. Moralidis
Myocardial Perfusion SPECT How to do it E. Moralidis Aristotelian University AHEPA Hospital Thessaloniki Myocardial perfusion SPECT procedure Stress Imaging Data analysis and reporting Myocardial perfusion
More informationNon-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 7 Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease A Summary of Evidence-Based Analyses Presented to
More informationmsv Stress dose (mci) Stress dose (MBq)
Supplemental Table 1. A Sample Weight Based Dosing for 99m Tc Sestamibi MPI Using a Dedicated Cardiac SPECT Scanner Weight range Rest (mci) Rest (MBq) msv Stress (mci) Stress (MBq) msv Total msv (rest
More informationThe Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6
The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review consultation document Review of Clinical Guideline (CG95) Chest pain of recent onset: Assessment and diagnosis
More informationDetection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve
The 2nd International Symposium on Physics, Engineering and Technologies for Biomedicine Volume 2018 Conference Paper Detection Of Functional Significance of Coronary Stenoses Using Dynamic 13 N-Ammonia
More informationCHRONIC CAD DIAGNOSIS
CHRONIC CAD DIAGNOSIS Chest Pain Evaluation 1. Approach to diagnosis of CAD 2. Classification of chest pain 3. Pre-test likelihood CAD 4. Algorithm for chest pain evaluation in women 5. Indications for
More informationSupplementary Online Content
Supplementary Online Content Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening
More informationChoosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018
Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Does it Really Matter? Brett C. Stoll, MD, FACC February 24, 2018 Conflicts of Interest
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir
More informationPrior Authorization for Non-emergency Cardiac Imaging Procedures
Attention: All Providers Prior Authorization for Non-emergency Cardiac Imaging Procedures The N.C. Medicaid Program is considering implementation of a prior authorization (PA) program for non-emergency
More informationMyocardial viability testing. What we knew and what is new
Myocardial viability testing. What we knew and what is new Dr B K S Sastry, MD, DM. CARE Hospitals, Hyderabad What is Viability Viability Dysfunctional myocardium subtended by diseased coronary arteries
More informationFundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC
Fundamentals of Nuclear Cardiology Terrence Ruddy, MD, FRCPC, FACC Objectives To understand the Principles of Nuclear Cardiac Imaging Radiotracers Image acquisition and processing Stress protocols To appreciate
More informationSingle Photon Emission Computed Tomography for the Diagnosis of Coronary Artery Disease
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 8 Single Photon Emission Computed Tomography for the Diagnosis of Coronary Artery Disease An Evidence-Based Analysis Presented to the Ontario
More informationUniversity of Groningen. Quantitative CT myocardial perfusion Pelgrim, Gert
University of Groningen Quantitative CT myocardial perfusion Pelgrim, Gert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationThe role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease
The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease G.P. Spanos, MSc, Phd Head of CardioVascular Imaging Tomographia Diagnostic Center Cardiovascular magnetic
More informationFamily history of coronary artery disease (CAD) is an
High Prevalence of Myocardial Perfusion Abnormalities on Positron Emission Tomography in Asymptomatic Persons With a Parent or Sibling With Coronary Artery Disease Stefano Sdringola, MD; Dhaval Patel,
More informationConflict of Interest Disclosure
Challenges and Opportunities for SPECT & PET in 2013: Implementing Latest Acquisition and Processing Protocols Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute
More informationMyocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas
Myocardial blood flow PET evaluation and quantification Dr. Erick Alexánderson Rosas Clinical case 62 year old female patient with a history of DM2 and chronic systemic hypertension She complains of progressive
More informationNuclear medicine in general practice. Dr Reza Garzan MD, FRACP, FAANMS
Nuclear medicine in general practice Dr Reza Garzan MD, FRACP, FAANMS Myocardial perfusion study Bone scans in general practice Thyroid scans in general practice Gamma camera Detection of gamma rays Myocardial
More informationMyocardial perfusion scintigraphy using rubidium-82 positron emission tomography
Published Online August 21, 2013 Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography Parthiban Arumugam *, Deborah Tout, and Christine Tonge Nuclear Medicine Centre, Central
More informationIntroduction to diagnostic accuracy meta-analysis. Yemisi Takwoingi October 2015
Introduction to diagnostic accuracy meta-analysis Yemisi Takwoingi October 2015 Learning objectives To appreciate the concept underlying DTA meta-analytic approaches To know the Moses-Littenberg SROC method
More informationWhich Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute
Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics
More informationTechnical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre
Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, 5-95 9 May 2008 Vienna International Centre Evidence-based Nuclear Cardiology: Imaging of CAD The
More informationCardiovascular Imaging
Cardiovascular Imaging Cardiovascular Imaging Cardio and Vascular Imaging Vascularization / Angiogenesis Cardiovascular Imaging metabolic imaging of the heart myocardial perfusion imaging Cardiac CT Vascularization
More informationNormal Stress-Only Versus Standard Stress/Rest Myocardial Perfusion Imaging
Journal of the American College of Cardiology Vol. 55, No. 3, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.09.022
More informationSystematic Reviews and meta-analyses of Diagnostic Test Accuracy. Mariska Leeflang
Systematic Reviews and meta-analyses of Diagnostic Test Accuracy Mariska Leeflang m.m.leeflang@amc.uva.nl This presentation 1. Introduction: accuracy? 2. QUADAS-2 exercise 3. Meta-analysis of diagnostic
More informationPatient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015
Patient-centered Imaging in Coronary Artery Disease Jason H Cole, MD, MS, FACC January 10, 2015 Non-invasive coronary imaging Non-invasive cardiac imaging has improved assessment of cardiac function, anatomy,
More informationA Snapshot on Nuclear Cardiac Imaging
Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the
More informationThe Value of Stress MRI in Evaluation of Myocardial Ischemia
The Value of Stress MRI in Evaluation of Myocardial Ischemia Dr. Saeed Al Sayari, MBBS, EBCR, MBA Department of Radiology and Nuclear Medicine Mafraq Hospital, Abu Dhabi United Arab Emirates Introduction
More informationMultiple Gated Acquisition (MUGA) Scanning
Multiple Gated Acquisition (MUGA) Scanning Dmitry Beyder MPA, CNMT Nuclear Medicine, Radiology Barnes-Jewish Hospital / Washington University St. Louis, MO Disclaimers/Relationships Standard of care research
More informationCardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?
Keenan Research Centre Li Ka Shing Knowledge Institute Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Howard Leong-Poi, MD, FRCPC Associate Professor of Medicine St.
More informationResearch Article. Open Access. Mansour Al Moudi 1,2, Zhong-Hua Sun 2. 1 Introduction
Journal of Geriatric Cardiology (2014) 11: 229 236 2014 JGC All rights reserved; www.jgc301.com Research Article Open Access Diagnostic value of 18 F-FDG PET in the assessment of myocardial viability in
More informationEvaluating Clinical Risk and Guiding management with SPECT Imaging
Evaluating Clinical Risk and Guiding management with SPECT Imaging Raffaele Giubbini Chair and Nuclear Medicine Unit University & Spedali Civili Brescia- Italy U.S. Congressional Budget Office. Technological
More informationTitle: What is the role of pre-operative PET/PET-CT in the management of patients with
Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June
More informationEvaluation of myocardial ischaemia
l2 TOPIC Evaluation of myocardial ischaemia Topic Contents Markers of myocardial injury and infarction 6 Myocardial territories supplied by coronary arteries 8 The 17 segment model 9 Regional assessment
More informationNon Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal
Non Invasive Diagnostic Modalities for Coronary Artery Disease Dr. Amitesh Aggarwal Ebers papyrus, ca. 1555 BCE If thou examine a man for illness in his cardia, and he has pains in his arms, in his breasts
More informationPushing the limits of cardiac CT. Steven Dymarkowski Radiology / Medical Imaging Research Centre
Pushing the limits of cardiac CT Steven Dymarkowski Radiology / Medical Imaging Research Centre 5 X 2013 Introduction Rapid technological advances and new clinical applications in cardiovascular imaging
More informationNew Challenges in Nuclear Cardiology Practice
New Challenges in Nuclear Cardiology Practice Brian G. Abbott, MD, FACC, FASNC, FAHA President, ASNC 2016 Associate Professor of Medicine Warren Alpert Medical School of Brown University Director, Cardiovascular
More informationLong-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease
Dan Med J 65/2 February 2018 DANISH MEDICAL JOURNAL 1 Long-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease Pia Hedegaard Johnsen 1, Martin Berg Johansen 1, 2
More informationCardiac Applications of Positron Emission Tomography Scanning
6.01.20 Cardiac Applications of Positron Emission Tomography Scanning Section 6.0 Radiology Subsection Effective Date December 15, 2014 Original Policy Date December 15, 2014 Next Review Date December
More informationSPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin
SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin Elmer Jasper B. Llanes, M.D. Nuclear Cardiology St. Luke s Medical Center Outline Ideal Physiologic Characteristics of MPI radioactive tracers
More informationHybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future
Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Contrast-Enhanced Coronary Computed Tomography Angiography (CCTA) Page 1 of 27 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Contrast-Enhanced Coronary Computed
More informationAHA Scientific Statement
AHA Scientific Statement Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease Consensus Statement From the Cardiac Imaging Committee, Council on Clinical
More informationComparison of Treadmill Exercise Versus Dipyridamole Stress With Myocardial Perfusion Imaging Using Rubidium-82 Positron Emission Tomography
Journal of the American College of Cardiology Vol. 45, No. 8, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.01.016
More informationAssessment of tumor response to chemotherapy in patients with breast cancer using 18 F-FLT: a meta-analysis
Original Article Assessment of tumor response to chemotherapy in patients with breast cancer using 18 F-FLT: a meta-analysis Sheng-Ming Deng 1,2,3, Wei Zhang 1, Bin Zhang 1,3, Yi-Wei Wu 1 1 Department
More informationIs computed tomography angiography really useful in. of coronary artery disease?
Is computed tomography angiography really useful in screening patients with high risk of coronary artery disease? Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular
More informationDivision of Cardiology, Department of Medicine and Department of Epidemiology, Johns Hopkins University, Baltimore - USA 2
HI Heart eissn 2036-2579 International 2014 ; 9 ( 1 ): 1-6 DOI: 10.5301/HEART.2014.12493 ORIGINAL ARTICLE Nuclear stress perfusion imaging versus computed tomography coronary angiography for identifying
More informationDiagnostic and Prognostic Value of Coronary Ca Score
Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium
More informationWelcome! To submit questions during the presentation: or Text:
Welcome! To participate in the interactive Q & A please do the following: 1. Download the Socrative Student App 2. Enter Teacher s Room Code: ZD0F3X5Q 3. Select Quiz: Intermountain Cardiac Stress Testing
More information